Drugs / HRV vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00383903 | Sep 2003 → Sep 2004 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00385320 | May 2001 → Apr 2003 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00383903 ↗ |
| Modality | Vaccine | “Oral Live Attenuated Human Rotavirus Vaccine” NCT00383903 ↗ |
| Route | Oral | “Two or three oral doses” NCT00383903 ↗ |